Objective To examine the dose-response relation between reduction in dietary sodium and
blood pressure change and to explore the impact of intervention duration. Design …

Since their approval, thiazolidinediones (TZDs) have been used extensively as insulin-
sensitizers for the management of type 2 diabetes mellitus (T2DM). Activation of peroxisomal …

Salt sensitivity of blood pressure (SSBP) is an independent risk factor for cardiovascular
morbidity and mortality that is seen in both hypertensive and normotensive populations …

Obesity and diabetes can lead to heart failure with preserved ejection fraction (HFpEF),
potentially because they both cause expansion and inflammation of epicardial adipose …

Non-alcoholic fatty liver disease (NAFLD), an accumulation of intra-hepatic triglycerides that
is often considered the hepatic manifestation of insulin resistance, is the most common …

Nonalcoholic Fatty Liver Disease (NAFLD) is a growing global phenomenon, and its
damaging effects in terms of cardiovascular disease (CVD) risk are becoming more …

The most common causes of chronic liver disease in the developed world—nonalcoholic
fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)—are the hepatic …

New‐onset diabetes after transplantation (NODAT) is a common comorbidity after renal
transplantation. Though metformin is the first‐line agent for the treatment of type 2 diabetes …

Aims/hypothesis Insulin resistance is frequently associated with hypertension and type 2
diabetes. The cytochrome P450 (CYP) arachidonic acid epoxygenases (CYP2C, CYP2J) …

Aims Salt-sensitive (SS) hypertension is accompanied by impaired vasodilation in the
systemic and renal circulation. However, the causal relationship between vascular …